Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 769-774

  Chunsuttiwat, Supamit ^d   Biggs, Beverley Ann ^a,b   Maynard, James ^c   Thamapalo, Suwit ^d   Laoboripat, Suchart ^d   Bovornsin, Sompote ^d   Charanasri, Uthen ^d   Pinyowiwat, Wason ^d   Kunasol, Prayura ^d  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c PATH   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; CHRONIC HEPATITIS; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFANT; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; THAILAND;

BCG VACCINE; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; POLIOVIRUS VACCINE, ORAL; THAILAND;

EID: 0030938153     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00226-5     Document Type: Article

References (20)

1. Beasley, R.P. and Hwang, L.Y. Hepatocellular carcinoma and hepatitis B virus. Semin. Liver Dis. 1984, 4, 113-121
2. Beasley, R.P., Hwang, L.Y., Lin, C.C. and Chien, C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981, 2, 1129-1133
3. World Health Organization Prevention of liver cancer. Report of a WHO meeting. WHO Tech. Rep. Ser. 1988, 691, 8-9
4. Grossman, R.A., Benenson, M.W., Scott, R.M., Snitbhan, R., Top, F.H.J. and Pantuwatana, S. An epidemiologic study of hepatitis B virus in Bangkok, Thailand. Am. J. Epidemiol. 1975, 101, 144-159
5. Thongcharoen, P., Panpatana, P., Wasi, C. et al. The incidence of hepatitis B surface antigen in tropical infections and liver diseases in Thailand. J. Med. Assoc. Thailand 1976, 59, 546-549
6. International Task Force on Hepatitis B Immunization. Hepatitis B immunization programs. Country profiles. Seattle: Program for Appropriate Technology in Health, 1988, pp. 1-3
7. Xu, Z.Y., Liu, C.B., Francis, D.P. et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics 1985, 76, 713-718
8. Stevens, C.E., Toy, P.T., Taylor, P.E., Lee, T. and Yip, H. Prospects for control of hepatitis B infection: implications of childhood vaccination and long-term protection. Pediatrics 1992, 90, 170-173
9. Maynard, J.E., Kane, M.A. and Hadler, S.C. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the expanded programme on immunization. Rev. Infect. Dis. 1989, 11suppl. 3, S574-S5778
10. Beasely, R.P., Hwang, L.Y., Lee, G.C. et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983, 2, 1099-1102
11. World Health Organization Report of the fourteenth meeting of the Global Advisory Group of the Expanded Programme on Immunization. Wkly Epidemiol. Rec. 1992, 3, 11-15
12. Ruff, T.A., Gertig, D.M., Otto, B.F. et al. Lombok hepatitis B model immunization project: toward universal infant hepatitis B immunization in Indonesia. J. Infect. Dis. 1995, 171, 290-296
13. The Gambia Hepatitis Study Group Hepatitis B vaccine in the expanded programme of immunisation: the Gambian experience. Lancet 1989, May 13, 1057-1060
14. Hsu, H.-M., Chen, D.-S., Chuang, C.-H. et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers. J. Am. Med. Assoc. 1988, 260, 2231-2235
15. Xu, Z.Y., Duan, S.C., Margolis, H.S. et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. J. Infect. Dis. 1995, 171, 54-60
16. Papaevangelou, G., Roumeliotou-Karayannis, A., Vissoulis, C., Richardson, S.C. and Krugman, S. Immunogenicity of a five-microgram dose of hepatitis B vaccine. J. Med. Virol. 1985, 15, 65-69
17. Da Villa, G., Piazza, M., Iorio, R. et al. A pilot model of vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas. J. Med. Virol. 1992, 36, 274-278
18. Hadler, S.C., Francis, D.P., Maynard, J.E. et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. NEJM 1986, 315, 209-214
19. Lieming, D., Mintai, Z., Yinfu, W., Shaochon, Z., Weiqin, K. and Smego, R.A.J. A 9-year follow-up study of the immunogenicity and long term efficacy of plasma-derived hepatits B vaccine in high-risk Chinese neonates. Clin. Infect. Dis. 1993, 17, 475-479
20. Pennie, R.A., O'Connor, A.M., Dulberg, C.S., Bottiglia, A., Manga, P. and Kang, C.Y. Low-cost hepatitis B vaccine improves uptake among self-paying health-care students. J. Med. Virol. 1992, 37, 48-53